Background: The risk of recurrent ischemia and bleeding after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) may vary during the first year of follow-up according to clinical presentation, and medical and interventional strategies. Methods: BleeMACS and RENAMI are 2 multicenter registries enrolling patients with ACS treated with PCI and clopidogrel, prasugrel, or ticagrelor. The average daily ischemic and bleeding risks (ADIR and ADBR) in the first year after PCI were the primary end points. The difference between ADBR and ADIR was calculated to estimate the potential excess of bleeding/ischemic events in a given period or specific subgroup. Results: A total of 19,826 patients were included. Overall, in the first year after PCI, the ADBR was 0.008085%, whereas ADIR was 0.008017% (P =.886). In the first 2 weeks ADIR was higher than ADBR (P =.013), especially in patients with ST-segment elevation myocardial infarction or incomplete revascularization. ADIR continued to be, albeit non-significantly, greater than ADBR up to the third month, whereas ADBR became higher, although not significantly, afterward. Patients with incomplete revascularization had an excess in ischemic risk (P =.003), whereas non–ST-segment elevation ACS patients and those on ticagrelor had an excess of bleeding (P =.012 and P =.022, respectively). Conclusions: In unselected ACS patients, ADIR and ADBR occurred at similar rates within 1 year after PCI. ADIR was greater than ADBR in the first 2 weeks, especially in ST-segment elevation myocardial infarction patients and those with incomplete revascularization. In the first year, ADIR was higher than ADBR in patients with incomplete revascularization, whereas ADBR was higher in non–ST-segment elevation ACS patients and in those discharged on ticagrelor.
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries / D'Ascenzo, Fabrizio; Biolè, Carloalberto; Raposeiras-Roubin, Sergio; Gaido, Federico; Abu-Assi, Emad; Kinnaird, Tim; Ariza-Solé, Albert; Liebetrau, Christoph; Manzano-Fernández, Sergio; Boccuzzi, Giacomo; Henriques, Jose Paulo Simao; Templin, Christian; Wilton, Stephen; Omedè, Pierluigi; Velicki, Lazar; Xanthopoulou, Ioanna; Correia, Luis; Cerrato, Enrico; Rognoni, Andrea; Fabrizio, Ugo; Nuñez-Gil, Iván; Montabone, Andrea; Taha, Salma; Fujii, Toshiharu; Durante, Alessandro; Song, Xiantao; Gili, Sebastiano; Magnani, Giulia; Autelli, Michele; Bongiovanni, Federica; Grosso, Alberto; Kawaji, Tetsuma; Blanco, Pedro Flores; Garay, Alberto; Quadri, Giorgio; Alexopoulos, Dimitrios; Queija, Berenice Caneiro; Huczek, Zenon; Paz, Rafael Cobas; González-Juanatey, José Ramón; Fernández, María Cespón; Nie, Shao Ping; Pousa, Isabel Muñoz; Kawashiri, Masa aki; Rettegno, Sara; Gallo, Diego; Morbiducci, Umberto; Conrotto, Federico; Dominguez-Rodriguez, Alberto; Valdés, Mariano; Cequier, Angel; Iñiguez-Romo, Andrés; Biondi-Zoccai, Giuseppe; Stone, Gregg; De Ferrari, Gaetano Maria.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 220(2020), pp. 108-115.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries|
|Data di pubblicazione:||2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.ahj.2019.10.001|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto:
|1-s2.0-S0002870319302765-main.pdf||2a Post-print versione editoriale / Version of Record||Non Pubblico - Accesso privato/ristretto||Administrator Richiedi una copia|
|Average daily ischemic vs. bleeding risk AHJ DAscenzo et al.pdf||2. Post-print / Author's Accepted Manuscript||Embargo: 11/11/2020 Richiedi una copia|